The assessment of concentration variations of interleukin 6 and C-reactive protein in patients with breast tumors;Ocena zmian stȩżeń, interleukiny 6 i białka C-reaktywnego u chorych na nowotwory piersi

Polski Merkuriusz Lekarski

Volumn 15, Issue 86, 2003, Pages 115-117

  Zakrzewska, Irena ^a   Kozłowski, Leszek ^b   Wojtukiewicz, Marek ^b  

^a Zaklad Lab Diagnostyki Klinicznej   (Poland)

^b NONE   (Poland)

Author keywords

Breast tumors; C reactive protein; Interleukin 6; Serum

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ARTICLE; ASSAY; BENIGN TUMOR; BREAST TUMOR; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; HUMAN; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL; ADOLESCENT; ADULT; AGING; BLOOD; CARCINOMA; FEMALE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADOLESCENT; ADULT; AGING; BREAST NEOPLASMS; C-REACTIVE PROTEIN; CARCINOMA; FEMALE; HUMANS; INTERLEUKIN-6; MIDDLE AGED;

EID: 0141537202     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Arias-Diaz J. i wsp.: Nitrite/nitrate and cytokine levels in bronchoalveolar lavage fluid of lung cancer patients. Cancer, 1994, 74 (5), 1546-1551.
2. Bobus W.J. i wsp.: Differential characteristics of two new tumorigenic cell lines of human breast carcinoma origin. In. J. Cancer, 1998, 77, 415-423.
3. Chelladurai M., Macintyre S.S., Kushner J.: In vivo studies of serum C-reactive protein turnover in rabbits. J. Clin. Invest., 1983, 71, 604.
4. Colombo M.P. i wsp.: Expression of cytokine genes including Il-6 in human malignant melanoma cell line. Melanoma Res., 1992, 2, 181-189.
5. Fu J. i wsp.: Effect of interleukin-6 on the growth of human lung cancer cell line. Chin. Med. J., 1998, 111, 265-268.
6. Gado K. i wsp.: Role of interleukin 6 in the pathogenesis of multiple myeloma. Cell Biol. Int., 2000, 24, 195-209.
7. Giri D., Ozen M., Ittmann M.: Interleukin-6 is an autocrine growth factor in human prostate cancer. Am. J. Pathol., 2001, 159 (6), 2159-2165.
8. Karczewska A. i wsp.: Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma. Cancer, 2000, 88 (9), 2061-2071.
9. Kishimoto T. i wsp.: Interleukin 6 family of cytokines and gp 130. Blood, 1995, 86, 1243-1254.
10. Kurebayashi J. i wsp.: Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6. Br. J. Cancer, 1999, 79, 707-717.
11. Lanfrancome L. i wsp.: Human peritoneal mesothelial cells produce many cytokines (granulocyte colony stimulating factor - CSF), granulocyte monocyte - CSF, macrophage CSF, interleukin 1 (IL-1), and IL-6 are activated and stimulated to grow by IL-1. Blood, 1992, 80, 2835-2842.
12. Lou W. i wsp.: Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat 3 signaling pathway. Prostate, 2000, 42, 239-242.
13. Nicola A.C. i wsp.: Inducible-production of interleukin-6 polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Blood, 1990, 75 (10), 2049-2052.
14. Ravoet C. i wsp.: Tumour stimulating effect of recombinant human interleukin 6. Lancet, 1994, 344, 1576-1577.
15. Reiter Z. i wsp.: Interleukin-6 protects ductal breast carcinoma cells from MHC-unrestricted cell-mediated cytotoxicity. Lymphokine Cytokine Res., 1992, 11, 175-181.
16. Strassman G. i wsp.: Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J. Clin. Invest., 1992, 89, 1681-1684.
17. Sulitzeanu D.: Immunosupresive factors in human cancer. Adv. Cancer Res., 1993, 60, 247.
18. Wojciechowska-Ła̧cka A. i wsp.: Odpowiedż ostrej fazy i stȩżenie interleukiny-6 w surowicy chorych na raka pluc poddanych radykalnej radioterapii. Now. Lek., 2000, 69 (8), 665-672.
19. Wook O.H.J., Revel M., Chebath J.: A soluble interleukin 6 receptor isolated from conditioned medium of human breast cancer cells is encoded by a differentially spliced mRNA. Cytokine, 1996, 8, 401-409.
20. Zakrzewska I., Poznański J.: Zmiany stȩżeń II-6 i CRP w surowicy chorych na nabłonkowe nowotwory jajnika po leczeniu cytostatycznym. Pol. Merk. Lek., 2001, 11 (63), 210-213.